title: Discounting role in cost-effectiveness of HPV vaccination by Starkie Camejo et al. (Public Health Vol 129(7):989-92).
authors.affiliation: Sanofi Pasteur MSD, Maidenhead, United Kingdom. Electronic address: thomas.butt.10@ucl.ac.uk.
authors.forename: Thomas
authors.initials: T
authors.lastname: Butt
authors.affiliation: Sanofi Pasteur MSD, Lyon, France.
authors.forename: Rosybel
authors.initials: R
authors.lastname: Drury
authors.affiliation: Sanofi Pasteur MSD, Lyon, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Largeron
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods*; D055088:Early Detection of Cancer / Q000191:economics*; D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*
chemical_list: D053918:Papillomavirus Vaccines